AzTrials
AzTrials

Neck PainEndPaRLNCT05818774

End-on Versus Parallel Radiofrequency Lesioning for Neurotomy of the Cervical Medial Branch Nerves

A study testing Radiofrequency neurotomy (RFN) of Cervical Medial Branch Nerves (CMBNn) with parallel lesioning and Radiofrequency neurotomy (RFN) of Cervical Medial Branch Nerves (CMBNn) with end-on lesioning with multitined trident cannulae in people with Neck Pain and Zygapophyseal Joint Arthritis, run by University Health Network, Toronto at 3 sites in 2 countries.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Aim of the EndPaRL study is to compare the efficacy and effectiveness of the two techniques utilizing sharp straight conventional radiofrequency needle with a trident needle for radiofrequency neurotomy of Cervical Medial Branch Nerves (CMBNs), in patients presenting with chronic, moderate-to-severe, neck pain due to… Read more about this study

Who is it for?
Ages 18 to 85 years
Conditions the study is for
Neck Pain, Zygapophyseal Joint Arthritis
What is being tested?
Radiofrequency neurotomy (RFN) of Cervical Medial Branch Nerves (CMBNn) with parallel lesioning and Radiofrequency neurotomy (RFN) of Cervical Medial Branch Nerves (CMBNn) with end-on lesioning with multitined trident cannulae
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
72 participants
Where
3 sitesin 2 countries
Study dates
10 Mar 2023to Mar 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patient of either gender aged 18-85 years
  • Predominant axial (non-radicular) neck pain for at least 3 months
  • 7-day average NRS score for neck pain ≥ 5/10 at baseline evaluation
  • Moderate or greater functional impairment due to pain, defined as NDI Questionnaire raw score of 15 out of 50 (≥30% )e Failure to respond to conservative medical management (pharmacologic, physical therapy) for at least 3 months;
  • Positive response to two consecutive diagnostic blocks of the CMBN with a short and long-acting anesthetic

Who cannot join

  • Participants with financial incentives or litigation associated with ongoing pain
  • Inability to complete assessment instruments
  • Chronic widespread pain
  • Prior RFN of the CMBN;
  • Severe mental health issues
  • Pregnancy or other reason that precludes the use of fluoroscopy
  • Untreated coagulopathy
  • Systemic or local infection at the time of screening.

Trial locations and contacts

3 sites in 2 countries. Contact the study team or a site near you to ask about taking part.

3 sites in 2 countries

Canada2 sites, 2 recruiting
  • Women's College Hospital

    Toronto, Ontario, M5S 1B3

    Anuj Bhatia, +1(416)603-5800 ext. 2308, Anuj.Bhatia@uhn.ca

    Didem Bozak, +1 (416)-323-6008, didem.bozak@wchospital.ca

    Recruiting
  • University Health Network (UHN)

    Toronto, Ontario, M5T 2S8

    Danielle Alvares, PhD, 416-603-5800 ext. 3517, danielle.alvares@uhn.ca

    Recruiting

Other trials in Canada

Spain1 site, 1 recruiting
  • Division of Pain Medicine, Department of Anesthesiology, Reanimation, and Pain Medicine, Hospital Clínic de Barcelona, University of Barcelona.

    Barcelona, Catalonia, 08036

    Guilherme Ferreira Dos Santos, MD, (+34) 657-757-477, guilhermesantos@campus.ul.pt

    Not yet recruiting

Other trials in Spain

About this study

Official title: A Prospective, Randomized, Double Blind Clinical Trial Comparing End-on Versus Parallel Radiofrequency Lesioning for Neurotomy of the Cervical Medial Branch Nerves: The EndPaRL Study

Aim of the EndPaRL study is to compare the efficacy and effectiveness of the two techniques utilizing sharp straight conventional radiofrequency needle with a trident needle for radiofrequency neurotomy of Cervical Medial Branch Nerves (CMBNs), in patients presenting with chronic, moderate-to-severe, neck pain due to cervical zygapophyseal joint osteoarthritis, as diagnosed by positive responses to two consecutive diagnostic blocks with local anesthetic of the CMBN.

Being tested
Radiofrequency neurotomy (RFN) of Cervical Medial Branch Nerves (CMBNn) with parallel lesioning, Radiofrequency neurotomy (RFN) of Cervical Medial Branch Nerves (CMBNn) with end-on lesioning with multitined trident cannulae
Keywords
Radiofrequency neurotomy, Cervical Medial Branch Nerves
Medical subject headings
Neck Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Radiofrequency neurotomy (RFN) of Cervical Medial Branch Nerves (CMBNn) with parallel lesioningProcedure or surgery

    Intervention type: RF nerve lesioning at 80-85 degree Celsius for 90 seconds Intervention name: Straight sharp conventional (SIS's technique)

    Intervention description:

    Technique as described in the SIS Practice Guidelines for parallel lesioning cannulae placement

  • Radiofrequency neurotomy (RFN) of Cervical Medial Branch Nerves (CMBNn) with end-on lesioning with multitined trident cannulaeProcedure or surgery

    Intervention type: RF nerve lesioning lesioning at 80-850 Celsius for 90 seconds Intervention name: End-on placement of the multitined trident cannulae

    Intervention description:

    Patient in lateral position, targeting joint position between the inferior C2 and superior C3 facets, the middle of the facet pillars for the third to fifth cervical levels, and the superior part of the sixth and seventh cervical facets.

Study groups in NCT05818774
Study groupRoleWhat they receive
RFN of CMBNn with end-on lesioning with multitIned trident cannulaeExperimentalIntervention type: RF nerve end-on lesioning at 80-850 Celsius for 90 seconds Intervention name: End-on placement of the multitined trident cannulae Intervention description: Patient in lateral position, targeting joint position between the inferior C2 and superior C3 facets, the middle of the facet pillars for the third to fifth cervical levels, and the superior part of the sixth and seventh cervical facets
Receives: Procedure: Radiofrequency neurotomy (RFN) of Cervical Medial Branch Nerves (CMBNn) with end-on lesioning with multitined trident cannulae
RFN of CMBNn with parallel lesioning with sharp straight conventional cannulae (SIS's technique)Active comparatorIntervention type: RF nerve parallel lesioning at 80-850 Celsius for 90 seconds Intervention name: Straight sharp conventional (SIS's technique) Intervention description: Technique as described in the SIS Practice Guidelines for parallel lesioning cannulae placement
Receives: Procedure: Radiofrequency neurotomy (RFN) of Cervical Medial Branch Nerves (CMBNn) with parallel lesioning

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Difference in mean Numerical Rating Scale (NRS) for pain scores

    Difference in the mean pain scores before and after procedure. Scale from 0 to 10, where higher scores mean worse outcome

    Measured: 3 months

  2. Proportion of patients with positive analgesic response

    Proportion of patients with positive analgesic response (≥50% reduction in the NRS score for neck pain compared to baseline)

    Measured: 3 months

Secondary outcomes (14)
  1. Difference in the mean Numerical Rating Scale (NRS) for pain scores

    Difference in mean NRS for pain scores at 1, 6 and 12 months after the RFA procedure. Scale from 0 to 10, where higher scores mean worse outcome

    Measured: at 1, 6 and 12 months

  2. Proportion of patients with positive analgesic response

    Proportion of patients with positive analgesic response (≥50% reduction in the NRS score for neck pain compared to baseline) at 1,3, 6 \& 12 months

    Measured: at 1,3, 6 and 12 months

  3. Proportion of patients with reduction in the Neck Disability Index (NDI) score

    Proportion of patients with ≥10% reduction in the NDI score at 1, 3, 6, and 12 months. Scale from 0 to 50, where higher scores mean worse outcome

    Measured: at 1, 3, 6, and 12 months

  4. Proportion of participants reporting improvement in the Patient Global Impression of Change (PGIC) scale

    PGIC score is a 7 point scale depicting a patient's subjective rating of overall improvement over time, as proportion of participants reporting improvement in the PGIC scale at 1, 3, 6, and 12 months

    Measured: at 1, 3, 6, and 12 months

  5. Difference in mean Pittsburgh Sleep Quality Index (PSQI) scores for sleep quality

    Difference in mean PSQI scores scores at 1, 3, 6, and 12 months. It has a range of 0-21; higher scores indicate worse sleep quality.

    Measured: at 1, 3, 6, and 12 months

  6. Difference in mean European Quality of Life (EQ-5D-5L score), a self-assessed, health related, quality of life questionnaire. It ranges from 5 to 25, where higher scores indicate worse outcome.

    Difference in mean EQ-5D-5L scores at 3, 6, and 12 months

    Measured: at 1, 3, 6, and 12 months

  7. Differences in duration of procedure between 2 groups

    Differences in duration of procedure in two groups

    Measured: day of procedure

  8. Differences in discomfort procedure between 2 groups

    Differences in patient discomfort of procedure

    Measured: day of procedure

  9. Differences in radiation dose of procedure between 2 groups

    Differences in radiation dose of procedure

    Measured: day of procedure

  10. Differences in cost of procedure between 2 groups

    Differences in cost of the procedures

    Measured: day of procedure

  11. Difference in opioid requirements in daily oral morphine equivalents between the groups

    Difference in opioid requirements in daily oral morphine equivalents in mg averaged over the 1 week before and at 3, 6, and 12 months follow-ups after the procedure

    Measured: at 3, 6, and 12 months follow-ups after the procedure

  12. Difference in average physical activity and sleep duration

    Difference in average physical activity and sleep duration as measured by wrist-worn actigraphy worn for 1 week before the procedure and 1 month after the procedure

    Measured: 1 week before the procedure and 1 month after the procedure

  13. Difference in incidence of peri-procedural complications and post-procedural adverse effects following the RFN procedure

    Difference in incidence of peri-procedural complications and post-procedural adverse effects following the RFN procedure in the two groups during and at 1, 3, 6, and 12 months after the procedures

    Measured: at 1, 3, 6, and 12 months after the procedures

  14. Patient assumption of the group assigned

    Patient assumption of the group assigned at 3 months after the RFN procedure

    Measured: at 3 months after procedure

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted19 Apr 2023
  2. Study start10 Mar 2023
  3. Primary completionDec 2027 (estimated)
  4. Study completionMar 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
72 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05818774
Sponsor's protocol ID
22-5634
Acronym
EndPaRL
Status last verified
Jan 2026
First submitted
5 Apr 2023
Last updated
16 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: There is no plan to share the IPD at the moment

Publications

  • MacVicar J, Borowczyk JM, MacVicar AM, Loughnan BM, Bogduk N. Cervical medial branch radiofrequency neurotomy in New Zealand. Pain Med. 2012 May;13(5):647-54. doi: 10.1111/j.1526-4637.2012.01351.x. Epub 2012 Mar 28.

    PubMed 22458772
  • Lord SM, Barnsley L, Wallis BJ, McDonald GJ, Bogduk N. Percutaneous radio-frequency neurotomy for chronic cervical zygapophyseal-joint pain. N Engl J Med. 1996 Dec 5;335(23):1721-6. doi: 10.1056/NEJM199612053352302.

    PubMed 8929263
  • Barnsley L. Percutaneous radiofrequency neurotomy for chronic neck pain: outcomes in a series of consecutive patients. Pain Med. 2005 Jul-Aug;6(4):282-6. doi: 10.1111/j.1526-4637.2005.00047.x.

    PubMed 16083457
  • Alomari A, Ferreira-Dos-Santos G, Singh M, Burnham T, Cao X, McCormick Z, Flamer D, Kumar P, Hoydonckx Y, Khan JS, Tumber PS, Alvares D, Bhatia A. End-on versus parallel radiofrequency lesioning for neurotomy of the cervical medial branch nerves: a study protocol of a prospective, randomized, double-blind clinical trial: the "EndPaRL" study. Trials. 2023 Nov 11;24(1):721. doi: 10.1186/s13063-023-07752-9.

    PubMed 37951900

Questions about this trial

What is this clinical trial studying?

A study testing Radiofrequency neurotomy (RFN) of Cervical Medial Branch Nerves (CMBNn) with parallel lesioning and Radiofrequency neurotomy (RFN) of Cervical Medial Branch Nerves (CMBNn) with end-on lesioning with multitined trident cannulae in people with Neck Pain and Zygapophyseal Joint Arthritis, run by University Health Network, Toronto at 3 sites in 2 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 16 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Canada, Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Danielle Alvares, PhD ((416) 603-5800 ext. 3517, danielle.alvares@uhn.ca), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Difference in mean Numerical Rating Scale (NRS) for pain scores (time frame: 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05818774, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in